½ðÄê»á¡¤(jinnianhui)½ð×ÖÕÐÅÆ³ÏÐÅÖÁÉÏ-Gold Annual Meeting

»¶Ó­À´µ½ÉϺ£Í¨Îµ£¡

021-54845833/15800441009

Æ·Öʱ£Ö¤ ¡¤ ͨεÊÔ¼Á

µ±Ç°Î»ÖÃ: Ê×Ò³ > ¿ÆÑвúÆ· > ¿ÆÑп¹Ìå > Ò»¿¹ > Íÿ¹BCL9¶à¿Ë¡¿¹Ìå

²úÆ·ÖÐÐÄ

×îвúÆ·

  • Íÿ¹BCL9¶à¿Ë¡¿¹Ìå

    ¹æ¸ñ£º
    ¼Û¸ñ£º£¤
    • Æ·ÅÆ : ͨεÉúÎï
    • Ŀ¼ºÅ : TW3316
    • Ó¦Óà : ½öÓÃÓÚ¿ÆÑÐʹÓÃ
    • »õÆÚ : ÏÖ»õ
    • ¹æ¸ñ £º100ul/200ul/25ul
  • ÉÌÆ·ÏêÇé
  • ²Î¿¼ÎÄÏ×
  • ˵Ã÷ÊéÏÂÔØ
  • ÉÌÆ·ÆÀÂÛ0
  • Ïà¹Ø²úÆ·

ÖÐÎÄÃû³Æ: Íÿ¹BCL9¶à¿Ë¡¿¹Ìå

Ó¢ÎÄÃû³Æ: Anti-BCL9 rabbit polyclonal antibody

±ð      Ãû: LGS

´¢      ´æ: Àä¶³£¨-20¡æ£©

¿¹      Ô­: BCL9

ËÞ      Ö÷: Rabbit

·´Ó¦ÖÖÊô: Human, Mouse

±ê ¼Ç Îï: Unconjugate

Ïà¹ØÀà±ð: Ò»¿¹

¿Ë¡ÀàÐÍ: rabbit polyclonal

¼¼Êõ¹æ¸ñ

Background:

BCL9 is associated with B-cell acute lymphoblastic leukemia. It may be a target of translocation in B-cell malignancies with abnormalities of 1q21. Its function is unknown. The overexpression of BCL9 may be of pathogenic significance in B-cell malignancies.

Applications:

ELISA, IHC

Name of antibody:

BCL9

Immunogen:

Fusion protein of human BCL9

Full name:

B-cell CLL/lymphoma 9

Synonyms:

LGS

SwissProt:

O00512

ELISA Recommended dilution:

5000-10000

IHC positive control:

Human thyroid cancer and human cervical cancer

IHC Recommend dilution:

25-100





¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿
¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿